Adjuvant therapy and molecular profiling for inoperable gliomas

Abstract Gliomas are the most common and lethal primary brain tumors. The mainstay of treatment for high-grade gliomas is maximal safe surgical resection followed by concurrent temozolamide chemotherapy and fractionated radiation therapy. Despite aggressive treatment, these tumors are diffusely infiltrative at presentation and relentlessly progressive with median survival